Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FY9WG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,319
Award facts
- Contract value 100% obligated
- $6,318.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $6,318.60 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 22, 2025, for HEPLISAV-B 20 MCG/0.5 ML syringes. This award was made without a set-aside designation, indicating it was competitively awarded. The delivery order is scheduled for completion by August 25, 2025, with performance to be executed at the company's Conshohocken facility. HEPLISAV-B is a recombinant hepatitis B vaccine used for immunization programs within the federal medical supply chain.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at approximately $1 billion through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent track record of meeting federal procurement requirements through open competition and its designation as a prime vendor for DLA's Medical Supply Chain underscore its critical role in supporting military medical operations.
Quick answers
Who was awarded contract SPE2DB25FY9WG?
SPE2DB25FY9WG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FY9WG worth?
The government has obligated $6,319 on SPE2DB25FY9WG.
Is contract SPE2DB25FY9WG an order under another contract?
Yes. SPE2DB25FY9WG is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9WG competed?
The extent of competition for SPE2DB25FY9WG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award